Abstract
Background: GEMINI trials demonstrated the therapeutic efficacy of vedolizumab (VDZ) in Crohn's disease (CD) and ulcerative colitis (UC). Research des......
小提示:本篇文献需要登录阅读全文,点击跳转登录